Long-Term Antibody Persistence After Hepatitis A Vaccination in Healthy Toddlers: Insights from Modeling
The HAV vaccine, Avaxim<sup>®</sup>, administered as one- or two-dose schedule, elicited long-lasting immunity in children, with a single dose sufficient to ensure long-term protection.
Authors
- Laurent Coudeville (ORCID: https://orcid.org/0000-0003-3651-2959)
- Adrián Jesús Navarrete Saravia
- Carlos Espul
- Christèle Augard
- Héctor Cuello (ORCID: https://orcid.org/0000-0002-5304-7545)
- Montserrat Vargas (ORCID: https://orcid.org/0000-0001-7650-0587)
- Catherine Bravo (ORCID: https://orcid.org/0000-0001-5916-1181)
Institutions
- University of Mendoza (AR)
- Sanofi (France) (FR)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1007/s40121-025-01278-0
- Primary Topic
- Hepatitis Viruses Studies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi